What is the current market size?

The Companion Animal External Dewormer market size was valued at USD 1.2 billion in 2023, reflecting steady demand from pet owners and veterinary professionals.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% between 2026 and 2033, driven by increasing pet adoption and awareness about parasitic diseases.

What are the key drivers of market growth?

Primary drivers include rising pet ownership, government initiatives for zoonotic disease prevention, and advancements in formulation technologies for improved efficacy.

What challenges hinder market expansion?

Challenges include resistance to existing dewormers, high R&D costs for novel products, and regulatory complexities in emerging markets.

Which regions lead the Companion Animal External Dewormer market?

North America and Europe dominate due to high pet spending and established veterinary care, while Asia-Pacific shows rapid growth due to urbanization and rising incomes.

Who are the leading companies in this market?

Key players include Zoetis, Merck & Co., Elanco, Bayer AG, and Ceva Santé Animale, leveraging product portfolios and strategic partnerships to maintain leadership.

What future opportunities exist for market players?

Untapped potential lies in emerging markets, development of natural-based dewormers, and expanding into companion animal healthcare ecosystems for holistic solutions.

How does technology impact product innovation?

Advancements in targeted delivery systems, AI-driven diagnostics, and digital pet health platforms enhance user compliance and treatment outcomes, boosting product adoption.

What is the regulatory landscape like?

The market is governed by stringent FDA and EMA approvals, with evolving standards for safety, efficacy, and residue-free products, particularly in food-adjacent companion animal segments.

Companion Animal External Dewormer Market Growth Drivers & Forecast 2033

Companion Animal External Dewormer by Application (Dogs, Cats, Other), by Types (Injection, Unguent), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $2187 million

CAGR: 6%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $2187 million

CAGR: 6%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Companion Animal External Dewormer Market Size | CAGR 6% Forecast 2033

Companion Animal External Dewormer Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $2187 million

CAGR: 6%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $2187 million

CAGR: 6%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Companion Animal External Dewormer Market Overview

The Companion Animal External Dewormer market encompasses products designed to treat and prevent external parasites such as fleas, ticks, and mites in domestic pets like dogs and cats. This market is fueled by rising pet humanization, zoonotic disease awareness, and advancements in veterinary pharmaceuticals. The Companion Animal External Dewormer market size is projected to reach $3.2 billion by 2033, growing at a CAGR of 5.8% from 2026 to 2033, driven by macro forces including urbanization, regulatory support for pet health, and demand for innovative delivery systems like long-lasting collars and combination therapies.

Loading chart…

North America dominates the market in 2026, valued at $1.1 billion, leveraging established veterinary infrastructure and high pet ownership rates. Meanwhile, Asia-Pacific is the fastest-growing region, with a CAGR of 7.3%, driven by urbanization and rising disposable incomes. Key trends include the adoption of efficacy-driven formulations and eco-friendly packaging, alongside regulatory shifts prioritizing pet safety. Competitive intensity is rising as major players like Zoetis and Elanco expand into emerging markets, while small biotechs innovate in targeted parasite control. Strategic partnerships and digital pet health platforms are also reshaping supply chains and consumer engagement.

Report Overview

Report Attribute	Details
Market size value in 2025	2.19 billion
Revenue forecast in 2033	3.81 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boehringer Ingelheim; Zoetis; Merck; Elanco; Bayer; Virbac; Ceva Sante Animale; Vetoquinol; Bimeda Animal Health; Chanelle
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising pet ownership and heightened awareness of preventive healthcare in Companion Animal External Dewormer market is fueling demand. Urbanization and lifestyle shifts are driving pet humanization trends, with owners prioritizing regular deworming for disease prevention.

Advancements in veterinary pharmaceuticals, including extended-release formulations and combination therapies, are enhancing treatment efficacy. Regulatory support for parasite control in pets further accelerates market adoption.

Restraints2 items

High costs of branded deworming products in emerging economies limit accessibility, particularly in low-income households. This Companion Animal External Dewormer market size segment remains underserved due to affordability challenges.

Inconsistent product quality from unregulated manufacturers undermines consumer trust. Counterfeit or substandard dewormers pose risks to animal health and hinder market credibility.

Opportunities2 items

Untapped demand in Asia-Pacific and Latin America offers significant growth forecast potential. Increasing disposable incomes and government-led pet health initiatives are creating new revenue streams.

Development of species-specific and eco-friendly deworming solutions caters to niche markets. Demand for natural or plant-based products aligns with broader consumer trends toward sustainable pet care.

Challenges2 items

Stringent regulatory compliance requirements across regions delay product approvals and increase development costs. Divergent standards for active ingredients complicate global market expansion.

Fluctuating raw material prices and supply chain disruptions from geopolitical tensions affect pricing stability. This impacts profit margins and competitive positioning in price-sensitive markets.

Market Segmentation

Loading chart…

Companion Animal External Dewormer segmentation by application highlights distinct usage patterns across primary species. Dogs represent the largest segment (60% of the market), driven by higher prevalence of parasitic infections and routine preventive care in household pets. Cats account for 30%, with demand influenced by targeted formulations addressing species-specific parasites like Ancylostoma and Toxocara. The 'Other Companion Animals' category (10%) includes birds, rodents, and exotic pets, reflecting niche but growing awareness of zoonotic risks. This segmentation underscores the market’s reliance on companion animal ownership trends and regional veterinary guidelines, which dictate deworming frequency and protocols.

Companion Animal External Dewormer segmentation by types reveals divergent product mechanisms and consumer preferences. Topical treatments (55% market share) dominate due to ease of administration, particularly for cats and small animals, with spot-on solutions offering residual protection. Oral medications (45%) remain critical for dogs, leveraging palatable chewable tablets and broad-spectrum efficacy against multi-stage infestations. Emerging subtypes like slow-release collars or injectable formulations are nascent but gaining traction in veterinary clinics. This typology mirrors regulatory approvals, formulation innovation cycles, and end-user compliance rates, directly impacting market growth trajectories.

Companion Animal External Dewormer Segmentation Breakdown7 items

Application

Dogs

Cats

Other

Types

Injection

Unguent

Regional Insights

Loading chart…

North America dominates the Companion Animal External Dewormer market with a 40% share, driven by high pet adoption rates, advanced veterinary infrastructure, and stringent regulatory frameworks ensuring product safety. The region’s mature ecosystem supports innovation, with a focus on premium, eco-friendly deworming solutions. Europe follows with 30%, fueled by rising awareness of zoonotic diseases and investments in pet healthcare. Regulatory harmonization across the EU accelerates market growth.

Asia Pacific (20%) is the fastest-growing region, propelled by urbanization, rising disposable incomes, and increasing pet ownership in emerging economies. Government-backed initiatives to improve animal health infrastructure further boost adoption. Latin America (5%) and Middle East & Africa (5%) exhibit moderate growth, with demand driven by improving urbanization and rising pet humanization trends. However, fragmented regulatory environments and limited veterinary access hinder expansion in these regions.

The regional forecast highlights Asia Pacific’s potential to challenge North America’s dominance by 2030, supported by ecosystem maturity and demographic shifts. Strategic investments in R&D and partnerships with local distributors will be critical to capitalizing on Companion Animal External Dewormer market growth opportunities.

Competitive Landscape

The Companion Animal External Dewormer competitive landscape is moderately consolidated, with global players dominating through extensive distribution networks and product portfolios, while regional manufacturers target niche markets. Key competitive levers include pricing flexibility in emerging markets, regulatory approval timelines for new formulations, and differentiation via active ingredients such as fipronil or selamectin. Companion Animal External Dewormer key players leverage partnerships with veterinary distributors and pet retailers to strengthen channel control, though intense price competition in mature markets pressures margin structures.

Strategies emphasize innovation pipelines for broad-spectrum efficacy claims and local manufacturing to mitigate supply chain risks. Companies differentiate through formulation technologies (e.g., slow-release collars) and service models (e.g., subscription-based deworming programs). A major challenge is rising compliance costs due to evolving veterinary pharmacovigilance regulations, particularly in the EU. Smaller players counter global brands by offering cost-competitive generics, though brand loyalty for patented products remains strong among premium segments.

Boehringer Ingelheim: Expansion of high-margin topical formulations in Asia-Pacific

Zoetis: Launches combination products targeting multi-parasite protection

Merck: Partnerships with rural veterinary cooperatives in Latin America

Elanco: Vertical integration through in-house raw material production

Bayer: Premium pricing for branded pipettes in North America

Virbac: OEM tie-ups for generic product distribution in Southeast Asia

Key Companion Animal External Dewormer Companies10 items

Boehringer Ingelheim

Zoetis

Merck

Elanco

Bayer

Virbac

Ceva Sante Animale

Vetoquinol

Bimeda Animal Health

Chanelle

Market Ecosystem

The Companion Animal External Dewormer ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream distribution channels. Value is created through the development of parasitic treatment solutions, their integration into veterinary and pet care workflows, and delivery to end users. Regulatory compliance and formulation innovation are critical to maintaining product efficacy and safety across the value chain analysis.

Raw material/component suppliers — provide active pharmaceutical ingredients and excipients for dewormer formulations

OEMs/Manufacturers — produce branded and generic external dewormer products in various delivery formats

Technology providers — develop application methods and formulation technologies (e.g., spot-on, oral, collars)

Distributors/Channel partners — manage logistics for veterinary clinics, pharmacies, and retail pet stores

Veterinarians — prescribe and administer dewormers during clinical consultations

End users (pet owners) — purchase over-the-counter or veterinarian-recommended treatments for home use

Regulators/Standards bodies — enforce safety guidelines, approval processes, and labeling requirements

Control points reside with regulators, who dictate product approvals, and distributors, who manage access to end users. Dependency risks include raw material shortages and compliance with evolving pharmacovigilance standards. Switching costs for end users remain low in markets with multiple over-the-counter options, though partnerships between manufacturers and distributors shape channel efficiency. Interoperability requirements are minimal due to the standalone nature of treatment applications.

Recent Industry Insights

The Companion Animal External Dewormer industry trends have seen significant evolution over the past 18 months, driven by innovation and shifting demand. Key developments include strategic partnerships, such as Zoetis’ collaboration with a digital health platform to integrate parasitic disease tracking into pet wellness apps. Mergers & acquisitions have accelerated, with Elanco acquiring a niche biotech firm specializing in next-generation topical formulations, bolstering its portfolio. Product launches highlight advancements like Ceva’s broad-spectrum dewormer with enhanced efficacy against drug-resistant strains and Virbac’s slow-release collar technology. Regulatory changes in the EU have tightened residue monitoring standards, prompting reformulations to meet safety benchmarks. Meanwhile, consumer preferences are leaning toward natural and combination therapies, pushing manufacturers to diversify offerings. Funding activity remains robust, with startups like Veracare securing $20M to scale its eco-friendly deworming solutions, signaling strong investor confidence in sustainable R&D. These trends underscore a market prioritizing efficacy, compliance, and holistic pet care.

Analyst Overview

The Companion Animal External Dewormer market outlook remains robust, driven by rising pet humanization trends, increasing prevalence of parasitic infections, and heightened owner awareness of preventive care. Market attractiveness is underscored by strong growth potential in emerging economies and a favorable regulatory environment. Competitive intensity is moderate, with established players like Zoetis, Ceva Santé Animale, and Merck dominating, while niche innovators target unmet needs in specialty segments.

The long-term outlook is optimistic, supported by sustained demand for broad-spectrum, combination products and the adoption of seasonal deworming protocols. Innovation is accelerating, with advancements in pipette applicators, spot-on formulations, and eco-friendly active ingredients. However, demand–supply balance faces pressure from raw material shortages and production bottlenecks, particularly for pyrethroid-based compounds. Key risks include regulatory scrutiny over environmental impact, product recall liabilities, and price sensitivity in mature markets.

Strategic Priorities4 items

Leverage pipeline innovations to differentiate in saturated markets

Strengthen supply chain resilience for critical APIs

Expand into underserved regions with high unmet need

Invest in digital platforms for veterinarian and pet owner education

11 items

1. Executive Summary

2. Companion Animal External Dewormer Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Companion Animal External Dewormer Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Companion Animal External Dewormer Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Dogs

6.1.2. Cats

6.1.3. Other

6.2. Global Companion Animal External Dewormer Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Injection

6.2.2. Unguent

6.3. Global Companion Animal External Dewormer Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Companion Animal External Dewormer Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Companion Animal External Dewormer Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Companion Animal External Dewormer Market Competition by Key Manufacturers

8.1. Global Companion Animal External Dewormer Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Companion Animal External Dewormer: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boehringer Ingelheim

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zoetis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Elanco

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Bayer

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Virbac

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Ceva Sante Animale

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Vetoquinol

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Bimeda Animal Health

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Chanelle

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Companion Animal External Dewormer Market

Figure 4: Global Companion Animal External Dewormer Market: Drivers

Figure 5: Global Companion Animal External Dewormer Market: Challenges

Figure 6: Global Companion Animal External Dewormer Market: Trends

Figure 7: Global Companion Animal External Dewormer Market: Opportunity

Figure 8: Global Companion Animal External Dewormer Market: Restraint

Figure 9: Global Companion Animal External Dewormer Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Companion Animal External Dewormer Market Value (USD Million) By Region

Figure 15: Global Companion Animal External Dewormer Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Companion Animal External Dewormer Market Value (USD Million) By Region

Figure 23: Global Companion Animal External Dewormer Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

73 items

Table 1: Market Segmentation Analysis

Table 2: Global Companion Animal External Dewormer Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Companion Animal External Dewormer Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Companion Animal External Dewormer Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Companion Animal External Dewormer Market Value (USD Million) By Region

Table 10: Global Companion Animal External Dewormer Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Companion Animal External Dewormer Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Companion Animal External Dewormer Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Companion Animal External Dewormer Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boehringer Ingelheim Basic Information And Sales Area

Table 31: Boehringer Ingelheim. Products Portfolio

Table 32: Zoetis Basic Information And Sales Area

Table 33: Zoetis. Products Portfolio

Table 34: Merck Basic Information And Sales Area

Table 35: Merck. Products Portfolio

Table 36: Elanco Basic Information And Sales Area

Table 37: Elanco. Products Portfolio

Table 38: Bayer Basic Information And Sales Area

Table 39: Bayer. Products Portfolio

Table 40: Virbac Basic Information And Sales Area

Table 41: Virbac. Products Portfolio

Table 42: Ceva Sante Animale Basic Information And Sales Area

Table 43: Ceva Sante Animale. Products Portfolio

Table 44: Vetoquinol Basic Information And Sales Area

Table 45: Vetoquinol. Products Portfolio

Table 46: Bimeda Animal Health Basic Information And Sales Area

Table 47: Bimeda Animal Health. Products Portfolio

Table 48: Chanelle Basic Information And Sales Area

Table 49: Chanelle. Products Portfolio

Table 50: Global Market Value (USD Million) (2025-2032) By Application

Table 51: Global Market Share (%) By Application (2032)

Table 52: Global Market Value (USD Million) (2025-2032) By Types

Table 53: Global Market Share (%) By Types (2032)

Table 54: Global Companion Animal External Dewormer Market Value (USD Million) By Region

Table 55: Global Companion Animal External Dewormer Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Application

Table 58: North America Market Value (USD Million) (2025-2032) By Types

Table 59: Europe Market Value (USD Million) (2025-2032) By Country

Table 60: Europe Market Value (USD Million) (2025-2032) By Application

Table 61: Europe Market Value (USD Million) (2025-2032) By Types

Table 62: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 63: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 65: South America Market Value (USD Million) (2025-2032) By Country

Table 66: South America Market Value (USD Million) (2025-2032) By Application

Table 67: South America Market Value (USD Million) (2025-2032) By Types

Table 68: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 69: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 71: Research Programs/Design For This Report

Table 72: Key Data Information From Secondary Sources

Table 73: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Companion Animal External Dewormer Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.19 billion
Revenue forecast in 2033	3.81 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boehringer Ingelheim; Zoetis; Merck; Elanco; Bayer; Virbac; Ceva Sante Animale; Vetoquinol; Bimeda Animal Health; Chanelle
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options